Mehdi Erdem

Dr. Mehdi Erdem

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2024 in Turkish Journal of Diabetes and Obesity
Verified
Journal Article
Open access
PDF file
SFSevgül Faki
Sevgül Faki
ATAbbas Ali Tam
Abbas Ali Tam
NINurcan İnCe
Nurcan İnCe
FAFeride Pınar Altay
Feride Pınar Altay
GKGÜLSÜM KARAAHMETLİ
GÜLSÜM KARAAHMETLİ
BÇBekir Çakır
Bekir Çakır
Aim: The increasing prevalence of diabetes mellitus (DM) brings about a rise in nephropathy, retinopathy, and neuropathy, which are microvascular complications of diabetes. The triglyceride-glucose (TyG) index is a convenient indicator of insulin resistance. It is related to microvascular and macrovascular complications among nonhospitalized patients with diabetes. However, it is unclear if the TyG index poses risks for vascular complications of type 2 DM in hospitalized patients. This study aims to investigate possible relations between this index and the risk of microvascular complications in hospitalized patients with type 2 DM. Material and Methods: The present study included 420 type 2 DM patients who were hospitalized in our clinic between February 2019 and May 2022. The TyG index was measured as fasting triglycerides mg/dL × fasting glucose mg/dL/2. The presence of microalbuminuria (MAU), diabetic neuropathy, chronic kidney disease (CKD), and retinopathy (DR) were evaluated. The data were analzed using IBM SPSS 22.0 statistical software. The level of statistical significance was taken as p

28 October 2025 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
ÖSÖzge Selin Özen Sekmek
Özge Selin Özen Sekmek
MEMehdi Erdem
Mehdi Erdem
SYSafiye Kızışar Yılmaz
Safiye Kızışar Yılmaz

16 September 2024 in Cureus
Verified
Journal Article
Open access
PDF file
MEMehdi Erdem
Mehdi Erdem
CACevdet Aydın
Cevdet Aydın
EKEkin Yiğit Köroğlu
Ekin Yiğit Köroğlu
ATAbbas Ali Tam
Abbas Ali Tam
SSSevilay Sezer
Sevilay Sezer
ZMZeynep Devran Muharremoğlu
Zeynep Devran Muharremoğlu
This study aimed to evaluate the diagnostic value of plasma and urinary metanephrines and determine their sensitivity, specificity, and correlation among patients with adrenal lesions, which required a multidisciplinary approach because of size, functional state, or malign appearance. This retrospective study of 152 patients with adrenal lesions was conducted at the Outpatient Clinics of Ankara Bilkent City Hospital at the Department of Endocrinology and Metabolism Diseases between August 2019 and February 2022. These patients were discussed at the Endocrinology and Surgery multidisciplinary council because of their adrenal lesions. Among them, 94 patients underwent adrenal surgery. Thirty patients with histologically proven pheochromocytoma, 36 with cortical nodular hyperplasia, four cases of adrenocortical carcinoma and 24 cases with angiomyolipoma were detected. According to the analysis, the most sensitive test in diagnosing pheochromocytoma was urinary fractionated metanephrine (90%), followed by plasma free metanephrines at 84 %. Conversely, the most specific test was plasma free normetanephrine (91.4%). A statistically significant correlation exists between plasma and urinary metanephrine; plasma normetanephrine levels were also significantly correlated with urine normetanephrine. These findings indicate that plasma and urine metanephrines are sensitive for detecting pheochromocytoma and can be used interchangeably.

14 January 2022
Verified
Book
Open access
PDF file
HUHakan Gökalp Uzun
Hakan Gökalp Uzun
AMAnar Mammadli
Anar Mammadli
MBMine Büşra Bozkürk
Mine Büşra Bozkürk
YSYasin Sarıkaya
Yasin Sarıkaya
SSSerdar Söner
Serdar Söner
GÜGüngör Üstün
Güngör Üstün
Hipertansiyon toplumda en sık görülen kardiyovasküler hastalıktır ve çoğunlukla sinsi bir seyir göstererek hedef organ hasarına sebep olur. Hipertansiyonun toplumdaki morbidite ve mortalite yükü üzerine azımsanmayacak bir etkisi vardır. Hipertansiyon; yaşam tarzı değişiklikleri ve medikal tedavi ile pek çok hastada kontrol edilebilmektedir ve nadiren girişimsel tedavilere ihtiyaç duyulmaktadır. Çoğunlukla asemptomatik seyretmesi nedeniyle hastaların çok azı tanı alır ve tedavi uyumsuzluğu nedeniyle tanı alanların çok azı uygun bir şekilde tedavi edilir. Sağlık alanında çalışanların neredeyse tümü çalışma hayatlarının belirli bir döneminde bu hasta grubuyla karşı karşıya kalmakta ve bu hastaların yönetiminde aktif rol oynamak durumunda kalmaktadır. Bütün bu sebepler bu kitabı yazmaya karar vermemizde itici güç oldu. Alışılagelmiş düşüncenin aksine hipertansiyon sadece kardiyologları ve iç hastalıkları uzmanlarını değil bütün disiplinleri ilgilendiren bir hastalıktır ve bu nedenle de biz Türkiye›nin dört bir yanından çeşitli uzmanlık alanlarından birçok seçkin yazarı bir araya getirmeyi planladık. Hipertansiyonun tanısından; girişimsel tedavilerine varana kadar hipertansiyon yönetimi enine boyuna tartışıldı. Ortaya çok güzel bir eser çıktı. Emek veren bütün yazarlarımıza ve Akademisyen yayınevinin emektar çalışanlarına sonsuz teşekkürler.

1 September 2026 in Endocrinology Research and Practice
Verified
Journal Article
Open access
PDF file
MEMehdi Erdem
Mehdi Erdem
SYSaliha Yildirim
Saliha Yildirim
SYSafiye Kızışar Yılmaz
Safiye Kızışar Yılmaz
SDSerife Ezgi Dogan
Serife Ezgi Dogan
BYBağdagül Yüksel
Bağdagül Yüksel
Objective: Dynapenia is increasingly recognized as a distinct clinical phenotype. However, its clinical significance in adults living with obesity, including its associations with psychological symptoms, cognitive function, and comorbidity burden, remains insufficiently characterized. This study aimed to evaluate the prevalence of dynapenia and its metabolic, psychological, and clinical correlates in adults living with obesity. Methods: This cross-sectional study included 140 adults living with obesity recruited from a tertiary endocrinology clinic. Handgrip strength was measured using a digital dynamometer and categorized as weak (dynapenic), normal, or strong according to age- and sex-adjusted reference values. Body composition was assessed using bioelectrical impedance analysis. Cognitive function, depressive symptoms, comorbidity burden, and physical activity levels were evaluated using the AD8 Dementia Screening Interview, Beck Depression Inventory (BDI), Charlson Comorbidity Index (CCI), and International Physical Activity Questionnaire-Short Form (IPAQ-SF), respectively. Group comparisons were performed using non-parametric tests, and correlations were assessed using Spearman coefficients. Results: Dynapenia was present in 20.0% of participants. Compared with strong individuals, those with dynapenia had higher body fat percentage, lower appendicular skeletal muscle mass index, and lower hemoglobin and creatinine levels (all P < .01). Dynapenia was also associated with a higher prevalence of hypothyroidism and a greater depressive symptom burden. Handgrip strength correlated positively with ASMI (ρ = 0.320, P < .001), creatinine (ρ = 0.245, P = .004), and hemoglobin (ρ = 0.249, P = 0.004), and negatively with body fat percentage (ρ = −0.374, P < .001) and BDI scores (ρ = −0.181, P = .036). No significant correlation was observed with AD8 scores. Higher CCI scores were associated with lower muscle strength. Conclusion: Dynapenia is common among adults living with obesity and is associated with adverse body composition, reduced biochemical markers of muscle integrity, greater depressive symptom burden, and higher comorbidity burden. Handgrip strength represents a simple, rapid, and integrative clinical marker that may support early risk stratification in obesity care. Cite this article as: Erdem M, Yıldırım S, Yılmaz SK, Doğan ŞE, Yüksel B. Handgrip strength as a multidimensional marker in adults living with obesity. Endocrinol Res Pract. Published online September 1, 2026. doi: 10.5152/erp.2026.26934.

8 October 2025 in Endocrinology Research and Practice
Verified
Journal Article
Open access
ABAdile Begüm Bahçecioğlu
Adile Begüm Bahçecioğlu
MEMehdi Erdem
Mehdi Erdem
Objective: This study aimed to describe distinct anti-thyroglobulin antibody (TgAb) trend trends and assess their association with clinical outcomes in papillary thyroid carcinoma (PTC). Methods: Twenty-two PTC patients with TgAb positivity (at diagnosis, postoperative follow-up, or post-Radioidoine (RAI) were retrospectively analyzed, classified into classical (declining/stable/ increasing) and nonclassical trend groups, and their clinical and outcome data was reviewed. Results: Classical TgAb patterns were observed in 14 patients (63.6%), including 12 with a declin ing pattern (median time to seronegativity: 20 months, range: 12-48) and 2 with persistently stable positivity. Among those with decreasing TgAb, 2 patients had previously experienced structural recurrence, both accompanied by transient TgAb rises. In the stable subgroup, 1 patient had per sistent but subcentimetric nodal disease without progression. Nonclassical patterns were identified in 8 patients (36.4%), distributed across 4 distinct scenarios: (1) Persistently very high TgAb remain ing undetectable without structural disease (n = 2), lasting ≥3 years, (2) transient de novo TgAb posi tivity following radioiodine treatment (RAIT) (n = 2), with spontaneous decline to negativity within 12-18 months, (3) late-onset de novo TgAb after RAIT, remaining stable without structural disease (n = 2), remaining stable (up to 5 years) without evidence of disease, (4) de novo TgAb rising with recurrence (n = 2), 1 presenting with nodal relapse and the other with pulmonary metastases, both showing TgAb decline after treatment. Conclusion: In PTC follow-up, TgAb trends were more informative than absolute levels: transient ele vations and de novo stable or persistently stable TgAb were less likely to indicate structural disease, whereas de novo rising TgAb strongly suggested recurrence. However, given the small, single-center cohort and retrospective design, these findings require confirmation in larger prospective studies. Cite this article as: Bahçecioğlu AB, Erdem M. A new perspective on anti thyroglobulin antibody patterns in the follow-up of papillary thyroid carcinoma. Endocrinol Res Pract. 2025;29(4):320-326.